Study of Alcoholic Hepatitis and Liver Disease

Study of Genetic Determinants in Alcoholic Hepatitis and Establishment of a Multicenter Prospective Cohort of Patients With Alcoholic Liver Disease

Recruiting Observational Study
Alcoholic Liver Disease Severe Alcoholic Hepatitis Alcoholic Cirrhosis
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Observational
Participants needed
447 (estimated)
Sponsor
University Hospital, Lille · Other
Who this trial is looking for

This trial is looking for people with alcoholic liver disease, including those with severe alcoholic hepatitis. Participants will help researchers understand how common these conditions are and how to assess their severity.

Are You a Good Fit for This Trial?

You may be able to join if

  • I drink more than 40 grams of alcohol a day if I am a woman, or more than 50 grams if I am a man.
  • I have consumed alcohol for more than 5 years.
  • I have had jaundice in the last 3 months.
  • My bilirubin level is more than 50 mg/l.

You may not be able to join if

  • I have another liver disease.
  • I have liver cancer.
  • I am HIV positive.

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Alcoholic hepatitis carries a risk of high mortality at short term, especially in its severe form. Its diagnosis is confirmed by liver biopsy. The prevalence of alcoholic hepatitis, severe or not severe, is poorly known and prospective data are needed. The present observational study aims to define the prevalence of alcoholic hepatitis among patients admitted for jaundice and determine their outco…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: For SAH group: * Alcohol consumption : * On average\> 40 g / day for women and 50 g / day for men * Duration:\> 5 years * Recent jaundice episode (less than 3 months) * Bilirubin\> 50 mg / l (85μmol / l) For NSAH group: \- Alcohol consumption : * On average\> 40 g / day…
Contacts

Alexandre Louvet, MD,PhD

03 20 44 55 97

alexandre.louvet@chru-lille.fr

CONTACT